Diabetes is Not Significantly Associated with Decreased First-Line Tuberculosis Drug Exposure

被引：0
|
作者：
Sturdy, Ann [1 ]
Romano, Federico [2 ]
Kipper, Karin [3 ]
Barrett, Jessica [1 ]
Whittington, Ashley [4 ]
Kon, Onn Min [1 ]
Oliver, Nick [1 ]
Pasca, Oscar Della
Cooke, Graham
机构：
[1] Imperial Coll London, Fac Med, London, England
[2] Univ Coll London UCL, Sch Pharm, London, England
[3] Epilepsy Soc, Analyt Chem Dept, London, England
[4] Northwick Pk Hosp & Clin Res Ctr, Dept Infect Dis, HARROW, England
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2025年 / 152卷
关键词：
D O I：
10.1016/j.ijid.2024.107549
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：43 / 44
页数：2
相关论文
共 50 条
  • [1] Adverse drug reactions associated with first-line anti-tuberculosis drug regimens
    Marra, F.
    Marra, C. A.
    Bruchet, N.
    Richardson, K.
    Moadebi, S.
    Elwood, R. K.
    FitzGerald, J. M.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (08) : 868 - 875
  • [2] Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity
    Kivrane, Agnija
    Ulanova, Viktorija
    Grinberga, Solveiga
    Sevostjanovs, Eduards
    Viksna, Anda
    Pole, Ilva
    Ozere, Iveta
    Bogdanova, Ineta
    Zolovs, Maksims
    Bandere, Dace
    Ranka, Renate
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2023, 132 : 19 - 20
  • [3] First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons
    Coninx, R
    Mathieu, C
    Debacker, M
    Mirzoev, F
    Ismaelov, A
    de Haller, R
    Meddings, DR
    LANCET, 1999, 353 (9157): : 969 - 973
  • [4] Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study
    Gao, Yazhou
    Forsman, Lina Davies
    Ren, Weihua
    Zheng, Xubin
    Bao, Ziwei
    Hu, Yi
    Bruchfeld, Judith
    Alffenaar, Jan-Willem
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1347 - 1358
  • [5] Genetic diversity of Mycobacterium tuberculosis and transmission associated with first-line drug resistance: a first analysis in Jalisco, Mexico
    Lopez-Avalos, Gladys
    Gonzalez-Palomar, Guadalupe
    Lopez-Rodriguez, Martin
    Vazquez-Chacon, Carlos Arturo
    Mora-Aguilera, Gustavo
    Gonzalez-Barrios, Juan Antonio
    Villanueva-Arias, Juan Carlos
    Sandoval-Diaz, Manuel
    Miranda-Hernandez, Ulises
    Alvarez-Maya, Ikuri
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 11 : 90 - 97
  • [6] The assessment of first-line anti-tuberculosis drug exposure, inflammatory biomarkers and pulmonary tuberculosis severity association with treatment response
    Igumnova, V.
    Kivrane, A.
    Viksna, A.
    Pahirko, L.
    Ozere, I.
    Bogdanova, I.
    Krams, A.
    Cirule, A.
    Grinberga, S.
    Sevostjanovs, E.
    Bandere, D.
    Ranka, R.
    FEBS OPEN BIO, 2022, 12 : 318 - 319
  • [7] Food significantly reduces plasma concentrations of first-line anti-tuberculosis drugs
    Kumar, Agibothu Kupparam Hemanth
    Chandrasekaran, Vedachalam
    Kumar, Angadi Kiran
    Kawaskar, M.
    Lavanya, J.
    Swaminathan, Soumya
    Ramachandran, Geetha
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 530 - 535
  • [8] Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis
    Shrestha, Sourya
    Knight, Gwenan M.
    Fofana, Mariam
    Cohen, Ted
    White, Richard G.
    Cobelens, Frank
    Dowdy, David W.
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (02):
  • [9] First-line tuberculosis drug resistance patterns and associated risk factors in Germany, 2008-2017
    Glasauer, Saskia
    Altmann, Doris
    Hauer, Barbara
    Brodhun, Bonita
    Haas, Walter
    Perumal, Nita
    PLOS ONE, 2019, 14 (06):
  • [10] Drug-drug interaction studies on first-line anti-tuberculosis drugs
    Bhutani, H
    Singh, S
    Jindal, KC
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (04) : 517 - 524
12345